272 results on '"Böhmer, Dirk"'
Search Results
2. Undetectable PSA predicts outcome after salvage radiotherapy for biochemical recurrence following radical prostatectomy
3. Advanced lung cancer patient benefits from minimally invasive costal resection and reconstruction: an effective palliative approach for costal metastasis
4. European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy—A Multicenter Study
5. Multi-institutional Development and External Validation of a Machine Learning Model for the Prediction of Distant Metastasis in Patients Treated by Salvage Radiotherapy for Biochemical Failure After Radical Prostatectomy
6. Development and External Validation of a Machine Learning Model for Prediction of Lymph Node Metastasis in Patients with Prostate Cancer
7. Ultrahypofraktionierte Radiotherapie beim Prostatakarzinom – ein neuer Standard?
8. Management, risk factors and prognostic impact of checkpoint-inhibitor pneumonitis (CIP) in lung cancer – A multicenter observational analysis
9. Bedeutung der Dauer einer begleitenden Hormontherapie zur definitiven Strahlentherapie
10. Totale neoadjuvante Therapie beim lokal fortgeschrittenen Rektumkarzinom: Eine sinnvolle Behandlungsoption?
11. Radiotherapy for hormone-sensitive prostate cancer with synchronous low burden of distant metastases
12. Recurrence patterns and impact of brain metastases in synchronous single organ oligometastatic lung cancer following local ablative treatment – A multicenter analysis
13. Thymidine phosphorylase induction by ionizing radiation antagonizes 5-fluorouracil resistance in human ductal pancreatic adenocarcinoma
14. FDG-PET/CT for pretherapeutic lymph node staging in non-small cell lung cancer: A tailored approach to the ESTS/ESMO guideline workflow
15. Moderately hypofractionated radiotherapy as definitive treatment for localized prostate cancer: Pattern of practice in German-speaking countries: A survey of the Prostate Cancer Expert Panel of the German Society of Radiation Oncology (DEGRO) and the Working Party on Radiation Oncology of the German Cancer Society (DKG-ARO)
16. Lead-time bias does not falsify the efficacy of early salvage radiotherapy for recurrent prostate cancer
17. Radiotherapy in nodal oligorecurrent prostate cancer
18. Reirradiation of High-Grade Gliomas: A Retrospective Analysis of 198 Patients Based on the Charité Data Set
19. Validation of Independent Prognostic Value of Asphericity of 18F-Fluorodeoxyglucose Uptake in Non–Small-Cell Lung Cancer Patients Undergoing Treatment With Curative Intent
20. Ultrahypofractionation of localized prostate cancer: Statement from the DEGRO working group prostate cancer
21. Side effects of proton beam therapy of choroidal melanoma in dependence of the dose to the optic disc and the irradiated length of the optic nerve
22. Assessing the Role and Optimal Duration of Hormonal Treatment in Association with Salvage Radiation Therapy After Radical Prostatectomy: Results from a Multi-Institutional Study
23. Salvage Radiotherapy for Relapsed Prostate Cancer after Radical Prostatectomy Is Associated with Normal Life Expectancy
24. Local ablative treatment for synchronous single organ oligometastatic lung cancer—A propensity score analysis of 180 patients
25. Impact of bladder volume on acute genitourinary toxicity in intensity modulated radiotherapy for localized and locally advanced prostate cancer
26. Effect of early salvage radiotherapy at PSA < 0.5 ng/ml and impact of post-SRT PSA nadir in post-prostatectomy recurrent prostate cancer
27. Rolle der kombinierten ADT und SRT nach radikaler Prostatektomie im primären Stadium pN0
28. Intermediäres Risikoprofil beim Prostatakarzinom: Rolle der kombinierten Hormon- und Strahlentherapie
29. Lacking Evidence to Recommend Neoadjuvant Chemotherapy and Definitive Radiotherapy in Muscle-Invasive Bladder Cancer: In response to: Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions published by Di Maria Jiang et al. Current Oncology Reports 2020, https://doi.org/10.1007/s11912-020-0880-5
30. Eine definitive Strahlentherapie mit einer Kurzzeit Androgendeprivationstherapie von 18 Monaten kann bei Patienten mit lokal begrenztem Prostatakarzinom mit hohen Risikofaktoren gegenüber dem Standard von 28–36 Monaten ausreichend sein
31. Use of androgen deprivation and salvage radiation therapy for patients with prostate cancer and biochemical recurrence after prostatectomy
32. Target Volume Definition in Primary Prostate Cancer Radiotherapy
33. Prostate Cancer
34. Defining biochemical recurrence after radical prostatectomy and timing of early salvage radiotherapy: Informing the debate
35. Dosimetric implications of inter- and intrafractional prostate positioning errors during tomotherapy: Comparison of gold marker-based registrations with native MVCT
36. Management of the Contralateral Neck in Unilateral Node-Positive Oral Squamous Cell Carcinoma
37. Radiation Therapy in Prostate Cancer
38. Hypofractionated radiotherapy for localized prostate cancer
39. Cataract development in patients treated with proton beam therapy for uveal melanoma
40. The treatment of metastatic, hormone-sensitive prostatic carcinoma
41. Proton Therapy for 166 Patients with Iris Melanoma: Side Effects and Oncologic Outcomes
42. Interfraction rotation of the prostate as evaluated by kilovoltage X-ray fiducial marker imaging in intensity-modulated radiotherapy of localized prostate cancer
43. Ultrahypofractionation of localized prostate cancer
44. German S3 Evidence-Based Guidelines on Focal Therapy in Localized Prostate Cancer: The First Evidence-Based Guidelines on Focal Therapy
45. Impact of Dose Escalation on the Efficacy of Salvage Radiotherapy for Recurrent Prostate Cancer—A Risk-Adjusted, Matched-Pair Analysis
46. Robotic Stereotactic Body Radiotherapy (SBRT) for Low- and Intermediate Risk Localized Prostate Cancer. Feasibility, Outcome and Toxicity.
47. Salvage Radiotherapy versus Observation for Biochemical Recurrence following Radical Prostatectomy for Prostate Cancer: A Matched Pair Analysis
48. German S3 Evidence-Based Guidelines on Focal Therapy in Localized Prostate Cancer: The First Evidence-Based Guidelines on Focal Therapy
49. MRI before and after external beam intensity-modulated radiotherapy of patients with prostate cancer: The feasibility of monitoring of radiation-induced tissue changes using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence
50. The German S3 Guideline Prostate Cancer: Aspects for the Radiation Oncologist
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.